Evidence map›Paper›PMID 33665397›Full record

ArticleHeliyon2021

Corrigendum to: "Inclusion of vitexin in β-cyclodextrin: preparation, characterization and expectorant/antitussive activities" [Heliyon 6 (12) (December 2020) e05461].

Eliatania Clementino Costa, Pedro Modesto Nascimento Menezes, Ricardo Lúcio de Almeida, Fabrício Souza Silva, Luciano Augusto de Araújo Ribeiro, James Almada da Silva, Ana Paula de Oliveira, Edigênia Cavalcante da Cruz Araújo, Larissa Araújo Rolim, Xirley Pereira Nunes

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Eliatania Clementino CostaRede Nordeste de Biostecnologia (RENORBIO), Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE, Brazil.
Pedro Modesto Nascimento MenezesRede Nordeste de Biostecnologia (RENORBIO), Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE, Brazil.
Ricardo Lúcio de AlmeidaPós-graduação em Biociências (PGB), Universidade Federal do Vale do São Francisco (UNIVASF), Petrolina, PE, Brazil.
Fabrício Souza SilvaPós-graduação em Biociências (PGB), Universidade Federal do Vale do São Francisco (UNIVASF), Petrolina, PE, Brazil.
Luciano Augusto de Araújo RibeiroPós-graduação em Biociências (PGB), Universidade Federal do Vale do São Francisco (UNIVASF), Petrolina, PE, Brazil.
James Almada da SilvaUniversidade Federal de Sergipe (UFS), Av. Gov. Marcelo Déda - São José, Lagarto, SE, Brazil.
Ana Paula de OliveiraRede Nordeste de Biostecnologia (RENORBIO), Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE, Brazil.
Edigênia Cavalcante da Cruz AraújoPós-graduação em Biociências (PGB), Universidade Federal do Vale do São Francisco (UNIVASF), Petrolina, PE, Brazil.
Larissa Araújo RolimRede Nordeste de Biostecnologia (RENORBIO), Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE, Brazil.
Xirley Pereira NunesRede Nordeste de Biostecnologia (RENORBIO), Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE, Brazil.
Universidade Federal Rural de Pernambuco · BRUniversidade Federal do Vale do São Francisco · BRUniversidade Federal de Sergipe · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2020.e05461.].

Identifiers

PMID33665397
PMCPMC7900693
OpenAlexW3130078426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.